Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL2 (C-X-C motif chemokine ligand 2) is a small cytokine belonging to the CXC chemokine family. It acts mainly as a chemoattractant for polymorphonuclear leukocytes—especially neutrophils—and hematopoietic stem cells. Its primary receptor on target cells is CXCR2. Elevated expression of CXCL2 has been observed in various pathological states, including obesity and stomach adenocarcinoma, and is implicated in immunoregulatory/inflammatory diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 2 (CXCL2).